Literature DB >> 15249797

Case studies in hypertension: managing calcium channel blocker-related peripheral edema.

Joel Handler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15249797      PMCID： PMC8109672          DOI： 10.1111/j.1524-6175.2004.02863.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  10 in total

1.  Dihydropyridine calcium channel blockers and peripheral side effects.

Authors:  A Sirker; C G Missouris; G A MacGregor
Journal:  J Hum Hypertens       Date:  2001-10       Impact factor: 3.012

2.  Pedal edema--not all dihydropyridine calcium antagonists are created equal.

Authors:  Franz H Messerli; Ehud Grossman
Journal:  Am J Hypertens       Date:  2002-11       Impact factor: 2.689

3.  Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

Authors:  L Hansson; L H Lindholm; T Ekbom; B Dahlöf; J Lanke; B Scherstén; P O Wester; T Hedner; U de Faire
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

4.  Oedema formation with the vasodilators nifedipine and diazoxide: direct local effect or sodium retention?

Authors:  H W van Hamersvelt; H J Kloke; D J de Jong; R A Koene; F T Huysmans
Journal:  J Hypertens       Date:  1996-08       Impact factor: 4.844

5.  Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

Authors:  M J Brown; C R Palmer; A Castaigne; P W de Leeuw; G Mancia; T Rosenthal; L M Ruilope
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

6.  Acute hypotensive, natriuretic, and hormonal effects of nifedipine in salt-sensitive and salt-resistant black normotensive and hypertensive subjects.

Authors:  A Damasceno; A Santos; M Pestana; P Serrão; P Caupers; P Soares-da-Silva; J Polónia
Journal:  J Cardiovasc Pharmacol       Date:  1999-09       Impact factor: 3.105

7.  Tolerability of long-term treatment with lercanidipine versus amlodipine and lacidipine in elderly hypertensives.

Authors:  Gastone Leonetti; Bruno Magnani; Achille Cesare Pessina; Alessandro Rappelli; Bruno Trimarco; Alberto Zanchetti
Journal:  Am J Hypertens       Date:  2002-11       Impact factor: 2.689

Review 8.  Side effects of calcium channel blockers.

Authors:  R P Russell
Journal:  Hypertension       Date:  1988-03       Impact factor: 10.190

Review 9.  Incidence of pedal edema formation with dihydropyridine calcium channel blockers: issues and practical significance.

Authors:  Matthew R Weir
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Sep-Oct       Impact factor: 3.738

Review 10.  Calcium channel blocker-related periperal edema: can it be resolved?

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jul-Aug       Impact factor: 3.738
  10 in total
  4 in total

1.  Therapeutic Potential of a Vasopressin V2 Receptor Antagonist for Calcium Channel Blocker-Associated Edema with Vasospastic Angina.

Authors:  Kojiro Toda; Masashi Fujino; Kota Murai; Teruo Noguchi
Journal:  Case Rep Cardiol       Date:  2022-07-08

2.  Human lymphatic vessel contractile activity is inhibited in vitro but not in vivo by the calcium channel blocker nifedipine.

Authors:  Niklas Telinius; Sheyanth Mohanakumar; Jens Majgaard; Sukhan Kim; Hans Pilegaard; Einar Pahle; Jørn Nielsen; Marc de Leval; Christian Aalkjaer; Vibeke Hjortdal; Donna Briggs Boedtkjer
Journal:  J Physiol       Date:  2014-08-28       Impact factor: 5.182

Review 3.  Calcium Channel Blockers Co-prescribed with Loop Diuretics: A Potential Marker of Poor Prescribing?

Authors:  Henry J Woodford
Journal:  Drugs Aging       Date:  2020-02       Impact factor: 3.923

Review 4.  Volume Management in Pulmonary Arterial Hypertension Patients: An Expert Pulmonary Hypertension Clinician Perspective.

Authors:  Lillian Hansen; Marsha Burks; Martha Kingman; Traci Stewart
Journal:  Pulm Ther       Date:  2018-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.